Association between serum testosterone changes and parameters of the metabolic syndrome

被引:0
作者
Kuribayashi, Sohei [1 ,2 ]
Fukuhara, Shinichiro [1 ,3 ]
Kitakaze, Hiroaki [1 ]
Tsujimura, Go [1 ]
Imanaka, Takahiro [1 ]
Ueda, Norichika [1 ]
Takezawa, Kentaro [1 ]
Kiuchi, Hiroshi [1 ,4 ]
Tachi, Ayaka [2 ]
Sakamoto, Jiro [2 ]
Abe, Toyofumi [2 ]
Tanigawa, Go [2 ]
Miyagawa, Yasushi [1 ,2 ]
Fujimoto, Takashi [5 ]
Nonomura, Norio [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Urol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan
[2] Sumitomo Hosp, Dept Urol, Osaka 5300005, Japan
[3] JCHO Osaka Hosp, Dept Urol, Osaka 5530003, Japan
[4] Osaka Cent Hosp, Dept Urol, Osaka 5300001, Japan
[5] Sumitomo Hosp, Phys Check Up Ctr, Osaka 5300005, Japan
关键词
Adiponectin; Longitudinal; Testosterone; Visceral fat; REPLACEMENT THERAPY; BODY-COMPOSITION; MEN; ADIPONECTIN; DEFICIENCY; STRENGTH; OBESITY; INSULIN; LEPTIN;
D O I
10.1507/endocrj.EJ24-0106
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Testosterone production is important in males, and various physical and psychological abnormalities occur in individuals with low testosterone levels. In the present study, we aimed to examine the effects of longitudinal changes in total testosterone levels in the same cohort. We included 178 male subjects who visited our hospital multiple times between 2018 and 2023 for medical checkups for at least 3 years. The median baseline age and total testosterone level (TT) of the cohort were 61 years and 4.74 ng/mL, respectively. The patients were divided into four groups based on the difference in TT (Delta TT) between baseline and last visit (Q1, n = 45; Q2, n = 45; Q3, n = 44; Q4, n = 44). Delta TT values ranged from -3.07 to -0.78 ng/mL in Q1, from -0.75 to -0.05 ng/mL in Q2, from -0.03 to 0.73 ng/mL in Q3, and from 0.75 ng/mL to 3.4 ng/mL in Q4. The median Delta TT were -1.22 for Q1, -0.35 for Q2, +0.19 for Q3, and +1.43 for Q4. Decreased TT tended to increase body weight, body mass index, waist circumference, and visceral fat (p for trend 0.0136, 0.0272, 0.0354, and 0.0032, respectively), and decrease adiponectin level (p for trend 0.0219). Herein, we found that decreased TT increases visceral fat and decreases adiponectin levels.
引用
收藏
页码:1125 / 1133
页数:9
相关论文
共 32 条
  • [1] Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials
    Bhasin, Shalender
    Ellenberg, Susan S.
    Storer, Thomas W.
    Basaria, Shehzad
    Pahor, Marco
    Stephens-Shields, Alisaj
    Cauley, Jane A.
    Ensrud, Kristine E.
    Farrar, John T.
    Cella, David
    Matsumoto, Alvin M.
    Cunningham, Glenn R.
    Swerdloff, Ronald S.
    Wang, Christina
    Lewis, Cora E.
    Molitch, Mark E.
    Barrett-Connor, Elizabeth
    Crandall, Jill P.
    Hou, Xiaoling
    Preston, Peter
    Cifelli, Denise
    Snyder, Peterj
    Gill, Thomas M.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (11) : 879 - 890
  • [2] Testosterone a key factor in gender related metabolic syndrome
    Bianchi, V. E.
    Locatelli, V.
    [J]. OBESITY REVIEWS, 2018, 19 (04) : 557 - 575
  • [3] The Free Hormone Hypothesis: When, Why, and How to Measure the Free Hormone Levels to Assess Vitamin D, Thyroid, Sex Hormone, and Cortisol Status
    Bikle, Daniel D.
    [J]. JBMR PLUS, 2021, 5 (01)
  • [4] Testosterone Replacement Therapy: Long-Term Safety and Efficacy
    Corona, Giovanni
    Sforza, Alessandra
    Maggi, Mario
    [J]. WORLD JOURNAL OF MENS HEALTH, 2017, 35 (02) : 65 - 76
  • [5] Longitudinal changes in plasma sex hormone concentrations correlate with changes in CT-measured regional adiposity among Japanese American men over 10 years
    Dinh, Kathryn T.
    Amory, John K.
    Matsumoto, Alvin M.
    Marck, Brett T.
    Fujimoto, Wilfred Y.
    Leonetti, Donna L.
    Boyko, Edward J.
    Page, Stephanie T.
    Rubinow, Katya B.
    [J]. CLINICAL ENDOCRINOLOGY, 2020, 93 (05) : 555 - 563
  • [6] Dudek P, 2020, ENDOKRYNOL POL, V71, P382, DOI [10.5603/EPa2020.0048, 10.5603/EP.a2020.0048]
  • [7] Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 Diabetes and Erectile Dysfunction
    Elsaied, Moustafa A.
    Masallat, Doaa
    Abdel-Hamid, Ibrahim A.
    [J]. AMERICAN JOURNAL OF MENS HEALTH, 2018, 13 (01)
  • [8] Finkelstein JS, 2013, NEW ENGL J MED, V369, P1011, DOI 10.1056/NEJMoa1206168
  • [9] Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial
    Fui, Mark Ng Tang
    Prendergast, Luke A.
    Dupuis, Philippe
    Raval, Manjri
    Strauss, Boyd J.
    Zajac, Jeffrey D.
    Grossmann, Mathis
    [J]. BMC MEDICINE, 2016, 14
  • [10] Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function
    Hackett, Geoffrey
    Cole, Nigel
    Mulay, Akhilesh
    Strange, Richard C.
    Ramachandran, Sudarshan
    [J]. WORLD JOURNAL OF MENS HEALTH, 2020, 38 (01) : 68 - 77